12-May-2016 - Evotec’s auto-immune spin-out Topas represents “a strategic opportunity” for the CRO, which reported strong first quarter sales this week.
19-Nov-2015 - A more patient-focused approach will expedite clinical trials and responsive CROs will have the competitive advantage, say AstraZeneca, EMD and Bayer.
22-Sep-2015 - Preclinical CRO NMI TT Pharmaservices is establishing a branch at Bayer’s campus in Germany.
05-Mar-2015 - Higher capacity utilization is improving prices across the non-clinical research sector according to Huntingdon Life Sciences CEO Brian Cass, who told Outsourcing-pharma.com the preclinical CRO may add scale to US...
26-Feb-2015 - Bayer has announced a strategic alliance to manufacture a preclinical candidate for small biotech Aronora.
12-Jan-2015 - PPD’s recently acquired biotech company X-Chem is launching a multi-target collaboration with Janssen Biotech. Financial terms of the deal were not disclosed.
23-Dec-2014 - Contract drug developer Evotec AG has achieved multiple milestones resulting in €8m ($9.8m) in revenue thanks to its collaborations with Bayer and Janssen Pharmaceuticals.
19-Dec-2014 - PPD’s biotech company X-Chem has licensed a second drug discovery program to Bayer Pharma, which follows on a multi-target collaboration the companies established in 2012.
15-Dec-2014 - A Covance investor is raising questions over Goldman Sachs’ involvement in providing advice to the CRO’s board, which recently accepted a $6.1bn takeover offer from industry peer LabCorp.
03-Nov-2014 - In an Outsourcing-Pharma sporting special, we reveal why GSK will not be at the Rio Olympics, why PPD has renewed its ironman triathlon sponsorship, and what became of BMS' partnership with Lance...
01-Oct-2014 - Evotec has announced positive milestone news this week, revealing that efforts to develop an endometriosis drug with Bayer have moved into preclinical testing.
05-May-2014 - Bayer has inked a deal with preclinical CRO Cenix BioScience to use its genome-scale RNA interference (RNAi) platform to target an undisclosed disease.
24-Jun-2013 - Pharma companies may be moving away from global CROs and towards more specialised early phase partners, according to German firm CRS who has inked a partnership deal with Bayer.
21-Mar-2013 - DKSH says its contract extension with Bayer in Cambodia strengthens its position as a service provider for pharmaceutical companies throughout Southeast Asia.
19-Jun-2012 - Bayer could spend up to 50 per cent more with Covance after it cuts ties with its other late phase CRO partner.
31-May-2012 - Covance has inked deals to provide preclinical services to Eli Lilly’s diabetes operations in China and late-stage support to Bayer Healthcare.
09-Dec-2010 - Prometheus Laboratories is performing mutational analyses on clinical samples from Bayer Schering Pharma as part of an extended services agreement.
26-Jul-2010 - Algeta has signed a deal making it the exclusive supplier of Alpharadin (radium-223) to Bayer, prompting the expansion of the production facility at IFE.
01-Apr-2009 - Bayer Technology Services GmbH, an affiliate of Germany's Bayer, has opened its first regional office in India, enlarging its presence in the fast-growing Asian markets.
04-Oct-2007 - German pharma firm Bayer is currently discussing with Indian company Biocon about a potential deal that would include the co-development of new biologics with an outsourcing element, according to Biocon.
17-Sep-2007 - Novartis and Bayer Schering Pharma have finally settled their disputes over multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with an agreement outlined in March now complete.
21-Aug-2007 - Analysts believe Bayer's research and development pipeline is well equipped to deal with looming patent expiries but that didn't stop rumours of a Novartis buyout last week.
27-Jun-2007 - Six months after a couple of failed Phase III trials, Nuvelo has reinstated clinical development for its blood clot dissolving drug, but it will have to go it alone after...
19-Jun-2007 - In the inevitable reshuffle that comes after a major acquisition, Bayer's healthcare division has today announced plans to cut 30 per cent of its drug pipeline.
02-Mar-2007 - Bayer Healthcare is cutting 1,400 research and development jobs, as the company integrates workers from recently acquired pharma business, Schering.